Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life
Mylan CEO Heather Bresch said that the company is reformulating EpiPen so that it will have a longer shelf life. She told the House Oversight Committee that reformulation should extend the drug out to 24 months from the current 18 months. (Source: Bloomberg)